Neuronal morphology in MeCP2 mouse models is intrinsically variable and depends on age, cell type, and Mecp2 mutation
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Rett Syndrome (RTT), a progressive neurological disorder characterized by developmental regression and loss of motor and language skills, is caused by mutations in the X-linked gene encoding methyl-CpG binding protein 2 (MECP2). Neurostructural phenotypes including decreased neuronal size, dendritic complexity, and spine density have been reported in postmortem RTT brain tissue and in Mecp2 animal models. How these changes in neuronal morphology are related to RTT-like phenotype and MeCP2 function, and the extent to which restoration of neuronal morphology can be used as a cellular readout in therapeutic studies, however, remain unclear. Here, we systematically examined neuronal morphology in vivo across three Mecp2 mouse models representing Mecp2 loss-of-function, partial loss-of-function, and gain-of-function mutations, at developmental time points corresponding to early- and latesymptomatic RTT-like behavioral phenotypes. We found that in Mecp2 loss-of-function mouse models, dendritic complexity is reduced in a mild, age-dependent, and brain region-specific manner, whereas soma size is reduced consistently throughout development. Neither phenotype, however, is altered in Mecp2 gain-of-function mice. Our results suggest that, in the cell types we examined, the use of dendritic morphology as a cellular readout of RTT phenotype and therapeutic efficacy should be cautioned, as it is intrinsically variable. In contrast, soma size may be a robust and reliable marker for evaluation of MeCP2 function in Mecp2 loss-of-function studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pyramidal neurons: dendritic structure and synaptic integration
Spruston, N. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2286 · Cited by 1,688
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
Guy, J., Hendrich, B., Holmes, M., Martin, J. E., & Bird, A. (2001) · Nature Genetics · doi:10.1038/85899 · Cited by 1,558
Marchetto, M. C. N., Carromeu, C., Acab, A., Yu, D., Yeo, G. W., Mu, Y., Chen, G., Gage, F. H., & Muotri, A. R. (2010) · Cell · doi:10.1016/j.cell.2010.10.016 · Cited by 1,329
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
Chen, R. Z., Akbarian, S., Tudor, M., & Jaenisch, R. (2001) · Nature Genetics · doi:10.1038/85906 · Cited by 1,275 · cited 7×
“Whether these dissimilar findings are consequences of brain region-specific or age-dependent regulation of neuronal morphology is difficult to evaluate, as studies have used different imaging techniques, including Golgi staining, neuron dye labeling, and fluorescent reporters, and differentMecp2mutant mice (Chen et al…”
InfluentialThe Story of Rett Syndrome: From Clinic to Neurobiology
Chahrour, M., & Zoghbi, H. Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.10.001 · Cited by 1,265 · cited 7×
“Phenotypic variability is present within the classic RTT profile, where affected girls differ by clinical severity (Chahrour and Zoghbi, 2007).”
InfluentialReversal of Neurological Defects in a Mouse Model of Rett Syndrome
Guy, J., Gan, J., Selfridge, J., Cobb, S., & Bird, A. (2007) · Science · doi:10.1126/science.1138389 · Cited by 1,230 · cited 1×
“Importantly, recent studies have shown that RTT-like symptoms can be ameliorated through the reintroduction of MeCP2 in mice (Giacometti et al., 2007; Guy et al., 2007; Lioy et al., 2011; Robinson et al., 2012).”
Zhou, Z., Hong, E. J., Cohen, S., Zhao, W.-N., Ho, H.-Y. H., Schmidt, L., Chen, W. G., Lin, Y., Savner, E., Griffith, E. C., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.037 · Cited by 877 · cited 4×
“The extent to which these factors influence cellular structure, however, is not well understood, as the use of different techniques and Mecp2 mouse models have made direct comparisons across studies difficult (Belichenko et al., 2008, 2009a; Chapleau et al., 2009; Cohen et al., 2011; Fukuda et al., 2005; Jentarra et a…”
InfluentialSelf-citationMild overexpression of MeCP2 causes a progressive neurological disorder in mice
Collins, A. L., Levenson, J. M., Vilaythong, A. P., Richman, R., Armstrong, D. L., Noebels, J. L., David Sweatt, J., & Zoghbi, H. Y. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh282 · Cited by 626
Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice
Tropea, D., Giacometti, E., Wilson, N. R., Beard, C., McCurry, C., Fu, D. D., Flannery, R., Jaenisch, R., & Sur, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812394106 · Cited by 593 · cited 8×
“, 2012) or IGF-1 treatment in mice and induced pluripotent stem cells (iPSCs) (Marchetto et al., 2010; Tropea et al., 2009).”
InfluentialLearning and Memory and Synaptic Plasticity Are Impaired in a Mouse Model of Rett Syndrome
Moretti, P., Levenson, J. M., Battaglia, F., Atkinson, R., Teague, R., Antalffy, B., Armstrong, D., Arancio, O., Sweatt, J. D., & Zoghbi, H. Y. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2623-05.2006 · Cited by 545
MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse Number
Chao, H.-T., Zoghbi, H. Y., & Rosenmund, C. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.018 · Cited by 511
A role for glia in the progression of Rett’s syndrome
Lioy, D. T., Garg, S. K., Monaghan, C. E., Raber, J., Foust, K. D., Kaspar, B. K., Hirrlinger, P. G., Kirchhoff, F., Bissonnette, J. M., Ballas, N., et al. (2011) · Nature · doi:10.1038/nature10214 · Cited by 496 · cited 1×
“Importantly, recent studies have shown that RTT-like symptoms can be ameliorated through the reintroduction of MeCP2 in mice (Giacometti et al., 2007; Guy et al., 2007; Lioy et al., 2011; Robinson et al., 2012).”
Kishi, N., & Macklis, J. D. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.07.006 · Cited by 445 · cited 16×
“…tissue (Armstrong, 2005) and in the locus ceruleus (Taneja et al., 2009), hippocampus CA2 (Chen et al., 2001), layer II/III somatosensory cortex (Kishi and Macklis, 2004), layer II/III motor cortex (Robinson et al., 2012), and layer V motor cortex (Stuss et al., 2012) of different Mecp2-null…”
InfluentialSelective dendritic alterations in the cortex of Rett syndrome
Armstrong, D., Dunn, J. K., Antalffy, B., & Trivedi, R. (1995) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199503000-00006 · Cited by 378
Cohen, S., Gabel, H. W., Hemberg, M., Hutchinson, A. N., Sadacca, L. A., Ebert, D. H., Harmin, D. A., Greenberg, R. S., Verdine, V. K., Zhou, Z., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.022 · Cited by 298 · cited 7×
“…genotypes: Previous studies have shown that disruption of MeCP2 results in deficits in neuronal organization, dendritic complexity and synaptic connectivity in the somatosensory cortex of both postmortem RTT tissue and mice (Cohen et al., 2011; Dani and Nelson, 2009; Kaufmann et al., 2000).”
InfluentialSelf-citationMolecular genetics of Rett syndrome: when DNA methylation goes unrecognized
Bienvenu, T., & Chelly, J. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1878 · Cited by 289
Belichenko, P. V., Wright, E. E., Belichenko, N. P., Masliah, E., Li, H. H., Mobley, W. C., & Francke, U. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.22009 · Cited by 272
Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2
Giacometti, E., Luikenhuis, S., Beard, C., & Jaenisch, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610593104 · Cited by 271 · cited 7×
“Importantly, recent studies have shown that RTT-like symptoms can be ameliorated through the reintroduction of MeCP2 in mice (Giacometti et al., 2007; Guy et al., 2007; Lioy et al., 2011; Robinson et al., 2012).”
InfluentialMecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons
Smrt, R. D., Eaves-Egenes, J., Barkho, B. Z., Santistevan, N. J., Zhao, C., Aimone, J. B., Gage, F. H., & Zhao, X. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.04.005 · Cited by 239 · cited 2×
“In addition, a developmental time window may exist in which neuronal morphology is more sensitive to MeCP2 function, as previous work has shown that newborn neurons in the hippocampus are severely affected by Mecp2 loss-of-function (Smrt et al., 2007).”
Fukuda, T., Itoh, M., Ichikawa, T., Washiyama, K., & Goto, Y.-I. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.6.537 · Cited by 221
Neuropathology of Rett syndrome
Armstrong, D. D. (2005) · Journal of Child Neurology · doi:10.1177/08830738050200082401 · Cited by 207
Neuropathology of Rett syndrome
Jellinger, K., Armstrong, D., Zoghbi, H. Y., & Percy, A. K. (1988) · Acta Neuropathologica · doi:10.1007/bf00688098 · Cited by 204
Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome
Robinson, L., Guy, J., McKay, L., Brockett, E., Spike, R. C., Selfridge, J., De Sousa, D., Merusi, C., Riedel, G., Bird, A., et al. (2012) · Brain · doi:10.1093/brain/aws096 · Cited by 157 · cited 19×
“Evidence supporting soma size as a reliable morphologic phenotype comes from existing rescue experiments, where activation of a quiescentMecp2 gene in adult mice results in partial restoration of dendritic complexity and length but a full restoration of soma size (Robinson et al., 2012).”
InfluentialChapleau, C. A., Boggio, E. M., Calfa, G., Percy, A. K., Giustetto, M., & Pozzo-Miller, L. (2012) · Neural Plasticity · doi:10.1155/2012/976164 · Cited by 48
Cited by
Autism spectrum disorder: neuropathology and animal models
Varghese, M., Keshav, N., Jacot-Descombes, S., Warda, T., Wicinski, B., Dickstein, D. L., Harony-Nicolas, H., De Rubeis, S., Drapeau, E., Buxbaum, J. D., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1736-4 · Cited by 536
Caldwell, A. L. M., Sancho, L., Deng, J., Bosworth, A., Miglietta, A., Diedrich, J. K., Shokhirev, M. N., & Allen, N. J. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01150-1 · Cited by 86
“To identify what these proteins are and whether they are altered in ND astrocytes, we compared protein secretion and gene expression from astrocytes from three mouse models of NDs to strain-matched WT control: (1) RTT, Mecp2 knockout (KO); (2) FXS, Fmr1 KO; (3) DS, Ts65Dn Down syndrome transgenic with one copy of the…”
BackgroundMethodSymeonides, C., Vacy, K., Thomson, S., Tanner, S., Chua, H. K., Dixit, S., Mansell, T., O’Hely, M., Novakovic, B., Herbstman, J. B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48897-8 · Cited by 66
Perineuronal net degradation rescues CA2 plasticity in a mouse model of Rett syndrome
Carstens, K. E., Lustberg, D. J., Shaughnessy, E. K., McCann, K. E., Alexander, G. M., & Dudek, S. M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci137221 · Cited by 57
Rietveld, L., Stuss, D. P., McPhee, D., & Delaney, K. R. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00145 · Cited by 39
Metadata
- Authors
- Wang, I.-T. J., Reyes, A.-R. S., & Zhou, Z.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 58
- Pages
- 3-12
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W1977802244
- Cited by
- 42
- References
- 24
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.